Takeda Pharmaceutical (TKPHF) Enterprise Value (2017 - 2025)
Historic Enterprise Value for Takeda Pharmaceutical (TKPHF) over the last 9 years, with Q4 2025 value amounting to -$5.3 billion.
- Takeda Pharmaceutical's Enterprise Value rose 656.83% to -$5.3 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$5.3 billion, marking a year-over-year increase of 656.83%. This contributed to the annual value of -$4.8 billion for FY2025, which is 4739.81% down from last year.
- According to the latest figures from Q4 2025, Takeda Pharmaceutical's Enterprise Value is -$5.3 billion, which was up 656.83% from -$5.1 billion recorded in Q3 2025.
- Takeda Pharmaceutical's Enterprise Value's 5-year high stood at -$3.2 billion during Q1 2024, with a 5-year trough of -$11.2 billion in Q2 2021.
- Over the past 5 years, Takeda Pharmaceutical's median Enterprise Value value was -$5.7 billion (recorded in 2024), while the average stood at -$6.8 billion.
- As far as peak fluctuations go, Takeda Pharmaceutical's Enterprise Value tumbled by 5786.42% in 2021, and later soared by 4440.37% in 2023.
- Takeda Pharmaceutical's Enterprise Value (Quarter) stood at -$10.5 billion in 2021, then increased by 24.37% to -$8.0 billion in 2022, then soared by 31.75% to -$5.4 billion in 2023, then dropped by 3.55% to -$5.6 billion in 2024, then rose by 6.57% to -$5.3 billion in 2025.
- Its last three reported values are -$5.3 billion in Q4 2025, -$5.1 billion for Q3 2025, and -$4.7 billion during Q2 2025.